Zidovudine-induced blockade of the expression and function of the erythropoietin receptor

Sudhir R. Gogu, James S. Malter, Krishna C. Agrawal

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Treatment of bone marrow progenitor cells (BMPC) with zidovudine (AZT) at various concentrations (0.5 to 20 muM) in vitro for 24 hr caused a concentration-dependent decrease in erythropoietin (Epo) receptor expression. The decrease in Epo receptors correlated with a decline in mRNA levels of the receptor. These results suggest that AZT-induced down-regulation of Epo receptor expression followed by loss of Epo-receptor mediated signal transduction is a significant contributory factor to AZT-induced erythroid toxicity.

Original languageEnglish (US)
Pages (from-to)1009-1012
Number of pages4
JournalBiochemical Pharmacology
Volume44
Issue number6
DOIs
StatePublished - Sep 25 1992

Fingerprint

Erythropoietin Receptors
Zidovudine
Signal transduction
Bone Marrow Cells
Toxicity
Signal Transduction
Bone
Stem Cells
Down-Regulation
Messenger RNA

ASJC Scopus subject areas

  • Pharmacology

Cite this

Zidovudine-induced blockade of the expression and function of the erythropoietin receptor. / Gogu, Sudhir R.; Malter, James S.; Agrawal, Krishna C.

In: Biochemical Pharmacology, Vol. 44, No. 6, 25.09.1992, p. 1009-1012.

Research output: Contribution to journalArticle

@article{91afa37978d24a5f9902db00b8dd453f,
title = "Zidovudine-induced blockade of the expression and function of the erythropoietin receptor",
abstract = "Treatment of bone marrow progenitor cells (BMPC) with zidovudine (AZT) at various concentrations (0.5 to 20 muM) in vitro for 24 hr caused a concentration-dependent decrease in erythropoietin (Epo) receptor expression. The decrease in Epo receptors correlated with a decline in mRNA levels of the receptor. These results suggest that AZT-induced down-regulation of Epo receptor expression followed by loss of Epo-receptor mediated signal transduction is a significant contributory factor to AZT-induced erythroid toxicity.",
author = "Gogu, {Sudhir R.} and Malter, {James S.} and Agrawal, {Krishna C.}",
year = "1992",
month = "9",
day = "25",
doi = "10.1016/0006-2952(92)90361-L",
language = "English (US)",
volume = "44",
pages = "1009--1012",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Zidovudine-induced blockade of the expression and function of the erythropoietin receptor

AU - Gogu, Sudhir R.

AU - Malter, James S.

AU - Agrawal, Krishna C.

PY - 1992/9/25

Y1 - 1992/9/25

N2 - Treatment of bone marrow progenitor cells (BMPC) with zidovudine (AZT) at various concentrations (0.5 to 20 muM) in vitro for 24 hr caused a concentration-dependent decrease in erythropoietin (Epo) receptor expression. The decrease in Epo receptors correlated with a decline in mRNA levels of the receptor. These results suggest that AZT-induced down-regulation of Epo receptor expression followed by loss of Epo-receptor mediated signal transduction is a significant contributory factor to AZT-induced erythroid toxicity.

AB - Treatment of bone marrow progenitor cells (BMPC) with zidovudine (AZT) at various concentrations (0.5 to 20 muM) in vitro for 24 hr caused a concentration-dependent decrease in erythropoietin (Epo) receptor expression. The decrease in Epo receptors correlated with a decline in mRNA levels of the receptor. These results suggest that AZT-induced down-regulation of Epo receptor expression followed by loss of Epo-receptor mediated signal transduction is a significant contributory factor to AZT-induced erythroid toxicity.

UR - http://www.scopus.com/inward/record.url?scp=0026785019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026785019&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(92)90361-L

DO - 10.1016/0006-2952(92)90361-L

M3 - Article

C2 - 1417927

AN - SCOPUS:0026785019

VL - 44

SP - 1009

EP - 1012

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 6

ER -